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ABSTRACT
The hematopoietic system has a highly regulated and complex structure in which cells are organized
to successfully create and maintain new blood cells. It is known that feedback regulation is crucial
to tightly control this system, but the specific mechanisms by which control is exerted are not
completely understood. In this work, we aim to uncover the underlying mechanisms in hematopoiesis
by conducting perturbation experiments, where animal subjects are exposed to an external agent
in order to observe the system response and evolution. We have developed a novel Bayesian
framework for optimal design of perturbation experiments and proper analysis of data collected
from these experiments. Here, we consider an experiment, where mice are exposed to a low dose
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of radiation, which reduces the number of hematopoietic stem cells but leaves the progenitor and
other hematopoietic cells in the bone marrow largely unchanged. We use a mechanistic differential
equation model that accounts for feedback and feedforward regulation on cell division rates and
self-renewal probabilities. A significant obstacle is that the experimental data are not longitudinal,
rather each data point corresponds to a different animal. We overcome this difficulty by developing a
hierarchical Bayesian framework with latent variables that capture unobserved cellular population
levels. We then use principles of Bayesian experimental design to optimally distribute time points at
which the numbers of bone marrow cells are observed. We evaluate our approach using synthetic
data and real experimental data and show that an optimal design can lead to better estimates of model
parameters.
1 Introduction
The hematopoietic system produces billions of mature myeloid and lymphoid blood cells from self-renewing hematopoi-
etic stem cells (HSCs) and multi-potent progenitors (MPPs) on a daily basis and facilitates massive cell increases in
response to pathological stresses [1]. This system must have in place a tightly regulated feedback control mechanism at
multiple levels to ensure an appropriate proportion of HSCs, MPPs, and mature cells. However, we do not yet have a
good understanding of the nature of the feedback regulation and how it plays a role in cell maintenance. In this work,
we present a hierarchical framework for modeling the hematopoiesis system with feedback control and regulation.
Our approach is based on a rigorous Bayesian methodology for fitting mechanistic mathematical models to empirical
data. Using a utility-based theory, we provide a rigorous procedure towards the determination of an optimal design
of experiment when the goal is to estimate the parameters of the hierarchical model. A key challenge is that in the
experiments used here, the data is not longitudinal as the method of data collection involves destruction of the source
(e.g., sacrifice of a mouse). Therefore, each data point corresponds to a different experiment.
There has been a longstanding effort to use mathematical models in order to understand hematopoiesis under normal and
diseased conditions, e.g., see [2, 3, 4, 5, 6]. These include ordinary differential equation (ODE) models that describe the
dynamics of simplified systems (e.g., [7, 8, 9, 10, 11, 12]), models that account for more realistic numbers of different
cell types and branching processes [13], as well as models that account for stochasticity [14, 15, 16, 17, 18, 19] and
spatial dynamics in the bone marrow [20]. In many cases, models were fitted using equilibrium cell counts, or limited
dynamic data, which yield point estimates for the parameters. In a few cases, uncertainties in parameter inference were
considered using Bayesian methods [21, 22, 23, 24, 25].
Here, we use a nonlinear ODE model that incorporates self-renewal, cell division, feedback and feedforward regulation
for a simplified description of hematopoiesis. In particular, we track only stem and multipotent progenitor cells.
Nevertheless, the model is flexible enough to describe the response to external perturbations and the subsequent return
to steady state.
We apply our model to empirical data obtained from perturbation experiments in mice subjected to low dose radiation.
We measure the numbers of HSCs and MPPs in the bone marrow to investigate the recovery dynamics and infer
model parameters and feedback mechanisms. Note that the mice can not be tracked longitudinally by taking repeated
measurements of cell numbers; rather, each mouse provides a single observation point because the mouse is sacrificed
to extract the bone marrow. This creates a statistical challenge for quantifying the system response since each data
point belongs to a different subject, for whom we do not have the baseline measurements prior to exposure to the
agent; that is, the number of cells is not known initially or at any other time prior to the measurement time and thus the
corresponding cell numbers are latent. To address this issue, we use a hierarchical Bayesian model where the initial
cellular counts for all the subjects are treated as latent variables to be inferred and the ODE model is used to interpolate
the cell numbers until the observation times. The main advantage of this approach is that it allows us to appropriately
integrate and align data from multiple subjects in a coherent, statistically rigorous manner Note that we still need to
determine how sensitive our estimates are to the choice of experimental design.
Designing experiments for investigating the hematopoietic process typically involves specifying a set of variables such
as: timing of the measurements, number of subjects per observation time, nature of the perturbation, etc. Our goal is to
determine the optimal values of these variables to maximize the information gain for the parameters of our ODE model.
Similar approaches have been used in other areas [26, 27, 28]. Using a Bayesian utility theory approach, we quantify
information gain about the ODE parameters over the space of all possible experimental designs. More specifically, we
use the Kullback-Leibler divergence [29, 30] to quantify the difference between the prior and posterior distributions of
the parameters. This way, we are able identify the design that provides the highest expected utility, e.g., maximum
information gain [31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43], which we call the optimal design.
2
To evaluate this approach, we first apply it to synthetic data and show that we can identify the ODE model parameters.
Next, we analyze real data from a bone marrow perturbation experiment. Investigating a finite set of experimental
designs, we find that the designs with higher number of observation times and possibly fewer subject replicates can
provide better parameter estimates compared to the designs with fewer observation times even if we use a higher number
of subject replicates. Also, we show that how we allocate the subjects over time matters. For example, designs with
more observations at later times can provide better estimates on feedback gains, whereas designs with more observations
at earlier times improve identification of cell division rates.
2 Materials and Methods
Experimental setup We consider an experimental set up where the hematopoietic system is perturbed and the
results of the perturbation are observed by measuring the numbers of the cell types of interest. We primarily consider
hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs), but other known cell types like lymphoid and
myeloid progenitors (CLPs, CMPs) or mature lymphoid and myeloid cells can also be quantified experimentally.
Throughout this paper, we will use simulated and real data based on the following experiment. We start with M
genetically identical mice that are kept under the same laboratory conditions. Each mouse is exposed to an external
perturbation, e.g. a light dose (50 cGy) of radiation, with the purpose of decreasing the number of HSCs (e.g., [44]).
These mice are sacrificed at different times after irradiation and the counts of HSCs and MPPs are obtained from the
bone marrow of each individual mice using flow cytometry. More information about the experimental materials and
methods can be found in the Supplemental Materials.
Data generation process We postulate that at time t0, HSC and MPP counts come from some distribution that
encapsulates normal biological variation among mice. For mathematical convenience, we assume that this distribution
is lognormal, or equivalently, that log-transformed unobserved true HSC and MMP counts come from two independent
normal distributions with means log(µHSC) and log(µMPP) respectively, with the same variance σb. Denoting these
latent log-transformed counts with a bivariate vector ui and their means with a vector µ for each mouse i = 1, . . . ,M ,
we can write our initial condition assumption as
ui ∼ N
(
log(µ), σ2b · I
)
, i = 1, . . . ,M. (1)
We are now ready to specify the distribution of observed HSC and MPP counts. First, we order mice in such a way that
mice indexed by 1, . . . , k correspond to animals, whose bone marrow is sampled immediately post perturbation. We
assume that conditionally on the true log-counts of HSCs and MPPs, the observed log-transformed counts yi = log(y∗i ),
where y∗i represents the raw counts, are normally distributed, with the mean being equal to the true counts and variance
σ2t that represents technical variation that arises due to the measurement error/noise.
For mice that are sacrificed right after the perturbation experiment, this assumption translates into the following
conditional distribution:
yi(t0) | ui ∼ N
(
ui, σ
2
t · I
)
, i = 1, . . . , k. (2)
The unconditional distribution for the HSC and MPP counts at the initial time t0 is derived from equations (1) and (2) as
yi(t0) ∼ N(log(µ), (σ2t + σ2b ) · I), i = 1, . . . , k. (3)
To model cell counts measured at time points after the initial time t0, we assume that the cellular population levels in
each mouse start from latent initial conditions and follow deterministic latent trajectories according to a mechanistic
process model. The latent population trajectories evolve for all times 0 < t ≤ tj until the moment tj when the mouse is
harvested and the cell counts are measured (with noise), see Figure 1A. The conditional distribution of the observed
HSC and MPP cell counts after the initial time given latent initial conditions is
yj(tj) | uj ∼ N(log(x(uj ,θ, tj)), σ2t · I), j = k + 1, . . . ,M, (4)
where x(uj ,θ, tj) is a bivariate vector of HSC and MPP counts for mouse j that started with latent counts uj and
evolved according to some process with parameters θ up to time tj . Note that equation (4) does not include the
biological noise term explicitly since it is already included in the model for initial cell counts. This approach implies
that the HSC and MPP trajectories are latent and can be observed cross-sectionally only once, in contrast to typical
longitudinal studies, where repeated measures are taken from a cohort of animals/subjects followed over time.
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Figure 1: Illustration of the proposed latent variables approach and mechanistic model. A. Description of the
proposed latent variables approach. Each mouse’ cell counts are observed only once at the time of the mouse sacrifice
and bone marrow extraction. Cell counts before perturbation (e.g., low dose radiation) are allowed to be different
among mice due to normal biological variation. We model this by assuming each data point at at time t0 to be subject to
technical and biological variability. At times greater than t0, we assume each data point has a latent trajectory subject
to technical variability (shown in dashed). These latent trajectories are modeled using our mechanistic ODE model
subject to these initial conditions. B. The ODE lineage model consisting of HSC and MPP compartments. HSCs and
MPPs have the ability to self renew with probabilities p0 and p1 and divide at ratesη1 and η2). The HSCs self renewal
probabilities are negatively regulated by the MPPs and the MPPs division rates are negatively regulated by the HSCs.
See [45] and text for details.
Mechanistic model of the mean process The dynamical model for latent trajectories is based on classic cell lineage
models for describing the growth of hierarchically-organized tissues [8, 46, 47] where cells are arranged in a lineage
starting with HSCs that are followed by more differentiated cells downstream. Although there are many cell types in the
branched lineage that describes the hematopoietic system (e.g., [48, 49]), we focus here only on the least differentiated
types: the HSCs and MPPs that have the simple hierarchical relationship shown in Fig. 1B. This is because the
experiments suggest that the cell compartments downstream are largely unaffected by irradiation (data not shown) and
thus we assume that the downstream cells do not significantly influence the HSC and MPP dynamics. Further, for
simplicity we do not distinguish between the different types of HSC and MPP cells, which eliminates the need for
considering branching. Of course, the model can easily be extended to include more cell types and branching (e.g.,
[20, 13]) although this would require more data to constrain them.
In the mathematical model (Fig. 1B), we assume that the HSCs and MPPs have the ability to divide at the rates η˜∗1 and
η˜∗2 , respectively, and to undergo self-renewal with probabilities p
∗
0 and p
∗
1. Let xHSC and xMPP be the numbers of
HSCs and MPPs respectively, then their dynamics can be modeled using a system of ordinary differential equations:
x′HSC = (2p
∗
0 − 1)η˜∗1xHSC ,
x′MPP = 2(1− p∗0)η˜∗1xHSC + (2p∗1 − 1)η˜∗2xMPP ,
(5)
where ′ = d/dt.
The self-renewal probabilities and division rates should be subject to feedback regulation. Single cell RNA sequencing
data (scRNA-seq) can be used to identify putative feedback loops and sender and receiver cells. We re-analyzed data
from a scRNA-seq study of normal hematopoiesis that identified many interesting cell clusters whose transcriptomes
suggested pairwise combinations of cells expressing feedback ligands and their receptors [50]. Although the study did
not cleanly separate out different kinds of early stem/progenitor cells, the early stem/progenitors did cluster into two
groups, perhaps representing HSCs and MPPs. In these two groups, we were able to recognize several ligands and
receptors (such as ANGPT1 and CCL3 and their receptors), although we could not be certain about the sender and
receiver cell types.
Following [51], we hypothesized that ANGPT1 is secreted by HSCs and negatively regulates MPP division rates and
that CCL3 is produced by MPPs and negatively regulates HSC self-renewal [52]. These hypotheses will be tested in
future work. The feedback on HSC self-renewal can be modeled using a simple Hill function
p∗0 =
p0
1 + γ1xMPP
, (6)
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where p0 is the unregulated self-renewal probability and γ1 is the feedback gain. Note that we have implicitly assumed
that the concentration of the negatively regulating biomolecule (e.g., CCL3) is proportional to the cell population. This
approximation assumes that spatial variation of the biomolecule can be neglected and is similar to the those used in
[8, 46, 13]. Although the HSC division rates could be subject to similar feedback as p∗0 [46], we assume for simplicity
that these rates are constant: η˜∗1 = η1.
The negative feedforward loop on MPP division rates can be modeled as
η˜∗2 =
η˜2
1 + γ2xHSC
, (7)
where η˜2 is the unregulated MPP division rate and γ2 is the feedforward gain.
In principle, the MPP self-renewal probability p∗1 should also be subject to feedback regulation. Assuming this regulation
arises from more differentiated cell types (e.g., [8, 46, 13]), we can assume that p∗1 = p1 is constant here since the more
differentiated cells are largely unaffected by radiation. Since the MPP should not be able to fully self-renew, p1 < 0.5.
Therefore, we may rewrite the system in Eq. (8) as
x′HSC = (2p
∗
0 − 1)η1xHSC ,
x′MPP = 2(1− p∗0)η1xHSC − η∗2xMPP ,
(8)
where
η∗2 = η2/(1 + γ2xHSC), (9)
and η2 = (1− 2p1)η˜2.
The non-linear feedback and feedforward loops in the above model enable the tight control of growth, the establishment
of equilibria that are robust to large changes in parameter values and rapid regeneration of equilibia after perturbations
by external stimuli (e.g., [8, 46]), although the regeneration dynamics can exhibit oscillatory behavior. Finally, all the
ODE model parameters can be grouped in the vector θ = (p0, η1, η2, γ1, γ2).
Hierarchical Bayesian framework
The goal of our statistical framework is to link the dynamic mathematical model with empirical data. We use a latent
variables approach where the ODE model allows us to interpolate all the latent trajectories for the measurements that
are missing before a mouse is harvested. According to the assumed data generation process described above, equations
(3) and (4) define the likelihood function as the product of normal densities at time zero and at later times:
p(y | Θ) =
k∏
i=1
N
(
yi | log µ, σ2t + σ2b
)
×
M∏
j=k+1
N
(
yj | log x(uj ,θ, tj), σ2t
)
,
(10)
where the vector Θ =
(
θ,uk+1:M , σ
2
b , σ
2
t ,µ
)t
includes all the parameters and latent variables of the hierarchical model,
and uk+1:M is a vector of latent initial cell counts of mice that are sacrificed after t0. Using a Bayesian approach, we
provide measures of uncertainty to all model parameters by calculating the posterior distribution of all the parameters:
p(Θ | y) ∝ p (y | Θ) p (Θ) . (11)
We assume a priori independence among the model parameters, resulting in the following prior distribution decomposi-
tion:
p(Θ) = p(θ) · p(u) · p(µ) · p(σ2b ) · p(σ2t ). (12)
Each of the parameters θi ∈ θ has a log-normal prior: log θi ∼ N(mθi , σ2θi), with the exception of p0 that requires a
logit transformation: logit(p0−
1
2
2 ) ∼ N(mp0 , σ2p0), since it is constrained between 0.5 and 1. Here, p(u) represents the
mice initial conditions according to equation (1), and p(µ) represents the prior on the mean of the initial conditions.
Finally, p(σ2b ) and p(σ
2
t ) represent the prior distributions on the biological and technical noises correspondingly. We
describe how we approximate the posterior distribution in Eq. (11) via Markov chain Monte Carlo (MCMC) in the
Computational Implementation section below.
5
Figure 2: Flow chart for computational implementation. Given a design dk, we sample a set of true parameter
values from the priors to obtain a synthetic data set generated from our mechanistic model using the latent variables
approach. Using the synthetic data, we obtain the posterior distribution and we calculate the utility value associated
to the nth synthetic data set. Once we have repeated this process N times, we calculate the mean utility for design
dk. If we do this for M designs, we are able to use this process to choose the design with the optimal mean utility
based on a decision criterion that typically depends on several constraints. For example, these constraints can vary from
minimizing the number of days or having a limit on the number of mice used.
Experimental design In the laboratory, there are multiple variables that can be modified when an experiment is
performed. Each combination of these variables defines an experimental design, which belongs to the set of all possible
designs, D. The optimal experimental design goal is to discriminate between all the possible designs by using a
suitable utility metric U(y, d) that quantifies the amount of information gain about the model parameters for a dataset
y collected under the design d ∈ D. The optimal design is determined by comparing the expected utility, where the
expectation is taken over all datasets, y, and model parameters, Θ, for the design d:
u(d) = EΘ,y [U(y, d)] =
∫
y
∫
Θ
U(y, d)p(y|Θ, d)p(Θ)dΘdy. (13)
For the utility metric U(y, d), we use the Kullback-Leibler (KL) divergence function that quantifies the information
gain as the difference between the prior and posterior distributions of the model parameters:
U(y, d) =
∫
Θ
log
(
p(Θ|y, d)
p(Θ)
)
p(Θ|y, d)dΘ. (14)
This utility is equivalent to the Shannon information gain [30]. We take a similar approach to calculate the marginal
expected utility for each parameter θj ∈ Θ individually:
Uj(y, d) =
∫
θj
log
(
pj(θj |y, d)
p(θj)
)
p(θj |y, d)dθj . (15)
Computational Implementation
Estimating p(Θ | y) We approximate the posterior distribution in Eq. (11) using an MCMC algorithm implemented
in a statistical computing software platform called Stan [53, 54]. Stan provides the No U-Turn MCMC sampler, which
allows the number of leapfrog steps during the warm-up phase of the MCMC simulation to be tuned. This is especially
useful in the case when parameters dependencies impose a complex geometry that makes the posterior sampling difficult.
However, for our hierarchical model, we show in Section 3 that we can successfully obtain samples from the posterior
distribution (11).
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Estimating U(y, d) Each design d ∈ D specifies the timing of the measurements and the number of mice replicates
in a hematopoiesis experiment. When the design is fixed, we can simulate data by first sampling one set of true
parameters from their corresponding prior distributions, and then sampling a synthetic dataset, y, that contains the
cellular population records for HSCs and MPPs according to the assumed data generating model. At the initial time t0,
the initial conditions for the latent trajectories are determined by sampling from two independent normal distributions
with means log(µHSC) and log(µMPP ) and equal variances σ2b + σ
2
t . From the initial conditions, the ODE model (8)
is forward-solved until the time when a trajectory is observed (mouse is sacrificed and the cell counts are observed).
Then a random bivariate vector is generated from the normal distribution with the mean equal to the ODE solution and
variance-covariance matrix Iσ2t . This process is repeated for all the latent trajectories to obtain the dataset y.
Given a generated dataset, we obtain MCMC samples from the posterior distribution. The posterior samples are used
to compute the value of the KL utility function in Eq. 13 by Monte Carlo integration using all the MCMC iterations
i = 1, . . . , n:
U(y, d) ≈ Û(y, d) = 1n
n∑
i=1
log
(
p(Θ(i)|y,d)
p(Θ(i))
)
= 1n
n∑
i=1
log
(
p(y|Θ(i),d)p(Θ(i))
p(y|d)
)
− log p(Θ(i))
= 1n
n∑
i=1
log p(y|Θ(i), d)− log p(y|d),
(16)
where Θ(i) is the i-th sample from the posterior distribution which is evaluated at the prior and posterior densities.
Note that the KL ratio in Eq. (16) requires an estimate of the marginal likelihood p(y|d), which we obtain by Bridge
Sampling — a thermodynamics integration method for calculating the marginal likelihood based on the posterior
distribution samples [55]. The marginal KL utility value for each parameter θj is also approximated via Monte Carlo:
Uj(y, d) ≈ Ûj(y, d) = 1
n
n∑
i=1
log
(
p̂(θ
(i)
j |y, d)
p(θ
(i)
j )
)
, (17)
where p̂(θj |y, d) is an approximation for the true marginal posterior density and it is estimated by a Gaussian kernel
density estimator using the posterior samples [56, 57]. This step is required since the analytical marginal posterior
density is generally not available. Note that the kernel density estimation can only be applied to the marginal utility
calculation since this approach is known to provide poor approximations for multiple-dimensional problems as in the
case of the joint utility calculation.
Estimating u(d). The overall mean utility in Eq. (13) is approximated by averaging dataset-specific utilities over N
simulated data:
u(d) ≈ û(d) = 1
N
N∑
k=1
Û(yk, d), (18)
where the utility Û(yk, d) is approximated using equation (16). For individual parameters, the mean utility value is
computed similarly:
uj(d) ≈ ûj(d) = 1
N
N∑
k=1
Ûj(yk, d), (19)
where Ûj(yk, d) is estimated using equation (17).
Finding the optimal design We consider a finite grid of designs d1, d2, . . . , dM that are relevant for the hematopoiesis
experiment. The optimal experimental design is determined by computing the expected utilities (18) and (19) for all the
designs and finding a design with the maximum utility. We illustrate the optimal design process in Figure 2.
3 Results
Successful parameter identification Because our proposed mechanistic model is complex, we first need to ensure
that the parameters in the model are identifiable. This is illustrated in Figure 3 using synthetic data. Here, we have
generated a dataset, where the HSCs and MPPs are observed at 7 consecutive days with 7 replicates for each day (49
mice in total). We have estimated the 5 ODE parameters, (p0, η1,η2,γ1, γ2), the 2 initial conditions, (µHSC and µMPP ),
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Figure 3: Parameter identification for a synthetic data set. Sampling from our prior distributions (see text), we
generate a synthetic data set from our ODE solution (Top Left). Solid curves correspond to ODE solutions for MPPs
(blue) and HSCs (black). Symbols (Data) correspond to HSC and MPP cell numbers from the ODEs but with the
addition of technical and biological noise following our latent variables framework (e.g., Eqs. (3) and (4)). The data
corresponds to observations on 7 consecutive days with 7 mice replicates per day. Using this synthetic data, in the
remaining graphs we show the prior (orange) and posterior (blue) distributions for the ODE parameters and the latent
HSC and MPP initial cell numbers together with the exact parameters and initial conditions used in the ODE model
(green). The ODE parameters, prior distributions and 95% credible intervals are shown in the Supplemental Materials
Table A-2.
7x7 Design p0 η1 η2 γ1 γ2 σt σb µ1 µ2
Mean Relative Bias 0.00 0.10 0.05 -0.08 -0.47 0.07 -0.31 -0.03 0.05
Mean Relative Width 0.04 0.60 0.72 1.34 2.52 0.36 1.98 0.10 0.11
Coverage 0.97 0.94 0.94 1.00 0.89 1.00 1.00 0.94 0.86
Table 1: Metrics for 60 simulations using 7 mice replicates during 7 days. The relative bias, relative width and coverage
are calculated according to equations (A-3), (A-6) and (A-4) shown on the Supplemental Materials.
the 2 error terms, (σt and σb), and the 84 latent trajectories (93 parameters in total). For this, we have used Stan [53, 54]
to obtain the posterior distribution of the model parameters. As we can see in Figure 3, there are significant changes
from prior to posterior distributions. Furthermore, we are able to recover the true parameter values within the 95%
posterior probability intervals.
To show that parameter identification is achieved under this design (7 days x 7 replicates), we have generated 60
synthetic datasets and obtained the posterior distribution for the model parameters. Using these results, we examine the
coverage of the model parameters by calculating the percentage of the times the true parameter values are included in
the 95% credible intervals (equation A-4). Additionally, we use the width of these intervals as a metric for the model
precision (equation A-6). We determine the relative bias for the MCMC simulations by using the posterior medians as
point estimates and calculate the normalized residuals using the true parameter values (equation A-3). The estimated
mean relative bias, mean relative width, and coverage of the 95% credible intervals for all the parameters in the 7 days
x 7 replicates design are shown in Table 1. As we can see, most model parameters have good coverage probabilities.
Also, except for γ2 and σb, the mean relative bias tends to be small.
Tables A-3 and A-4 in the Supplemental Materials provide more simulation results based on other designs illustrated in
Figure 2. In general, our results show that the true model parameters are included within the 95% credible intervals. We
also observe that designs with more data points allow for narrower posteriors, as quantified by the mean relative width,
but higher bias is observed in some parameters.
Next, we focus on quantifying information gain using the Bayesian utility theory described in the previous section. In
particular, we are interested in finding the optimal experimental setup that provides the highest information gain for
inferring the model parameters.
Low dose radiation targets HSCs for cell death As a proof of concept, we use our hierarchical model to fit and
obtain posterior distributions from preliminary data from a bone marrow perturbation experiment targeting stem cells.
In this experiment, low dose radiation (50 cGy) was applied to a number of mice following [58] where it was claimed
that low dose radiation decreases HSC numbers. This is consistent with what we observed as well, see Fig. A-2 in
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Figure 4: Parameter estimation for a real data set. Top Left. Preliminary data (symbols) obtained from mice that
were irradiated with 50 cGy and fits of our hierarchical model to this dataset where we show the median (dashed) of
the posterior distribution for the ODE solutions and the 95% Bayesian credible intervals (bands). Remaining graphs.
Plots of the prior and posterior distributions for the fitted ODE parameters and the mean of the latent HSC and MPP
initial conditions. Additional details on the priors and posterior distributions can be found on Supplemental Materials
Table A-1.
the Supplemental Materials. To observe the system dynamics in response to this perturbation, the HSC and MPP cell
numbers were obtained shortly after irradiation and at two other time points (days 0, 2 and 6). At each time point,
some of the mice were sacrificed, their bone marrows were extracted and sorted, and the cell numbers were determined
by flow cytometry (see Experimental Methods in the Supplemental Materials). While there were 13 mice in total,
seven mice were sacrificed at day 0, four were sacrificed on day 2 and two were sacrificed on day 6. Note the large
variability in the data, particularly in the MPP numbers on Fig. A-1. The data suggests that the HSCs and MPPs return
to equilibrium within one week.
Fig. 4(top left) shows the fits of the mechanistic model to the data for HSCs (black) and MPPs (blue). In particular, the
medians (dashed) of the posterior distribution of the ODE solutions are shown together with the 95% Bayesian credible
regions [59] (shaded). The ODE fit seems reasonable based on the small amount of experimental data. However, only
the HSCs initial conditions comparing experiment vs. control data (Fig. A-1) showed a significant shift between the
prior and posterior distributions (Fig. A-2). All the other parameters did not show a substantial shift in the posterior
distributions compared to the priors (Fig. 4, Table A-1, Fig. A-3), suggesting there is little information gained from this
data. Moreover, the Bayes Factor (e.g., [59]) between a model with feedback (Eq. (8)) compared to the same model
without feedback regulation (Eq. (8) with γ1 and γ2 identically zero) is equal to BF = 1.18, which indicates that there
is no strong evidence in favor of the model with feedback according to this limited dataset.
Utility Grid Search Since we know that the model parameters are identifiable using a sufficient amount of synthetic
data, the results in the previous section highlight the importance of finding a proper experimental design to maximize
information gain in the radiation experiment. To this end, we explore different experimental setups by varying the
number of mice collected per day and the timing of the measurements. That is, each design represents some number
of mice observed at some sampling frequency. We consider a finite number of experimental designs (70) to include
a varying amount of mice over different observation days. Our design space is defined as the following. The first
observation day starts at day 0 right after radiation, and more times are added until day 6 since it was shown in our
preliminary perturbation experiment that the system returns to equilibrium in less than a week. We also assume that the
number of mice observed per day could be 3, 4, 5, 6, or 7.
Exploring this finite experimental design space requires calculating the expected utilities for which we use 60 different
synthetic datasets per design (18, 19). As shown in Figure 5, the expected utilities show an increasing trend when the
number of replicates and the frequency of sampling increase. The values in this figure correspond to a fold change with
respect to the baseline design, 3 mice observed at day 0 and 6, with minimum utility. To better understand the scale, we
choose several designs (boxed), compare their mean utilities, and plot the corresponding ODE credible regions. The
plots provide a visual explanation on how higher information gain, as quantified by the mean utility values, correspond
to designs with higher number of data points, which in turn provide narrower credible regions (Figure 5). Note that
higher mean utillity can be interpreted as lower uncertainty regarding the system dynamics.
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Figure 5: Mean utility values for sampled designs. Left Column. The mean utility heat map across all model
parameters following the simulation process presented in Fig. 2. Utility values correspond to a fold change to the
minimum utility value, which corresponds to 3 mice observed at days 0 and 6. The higher utility fold changes correspond
to a greater information gain. The boxes labeled A, B and C correspond to 3 designs with increasing mean utility value.
Right Column. The medians and 95% Bayesian Credible Intervals (bands) of the posterior distributions for the ODE
solutions using the same synthetic dataset for the labeled designs. The parameter values additional details on the prior
and posterior distributions are available in the Supplemental Materials Table A-2.
Parameter Utility The expected utility provides an overall metric for information gain by averaging over all model
parameters. Alternatively, to quantify the amount of information provided by the observed data with respect to a specific
model parameter, we can use the individual parameter utilities. This way, we can better understand how data affects
identification of certain model parameters.
Additionally, obtaining individual parameter utilities allows us to find a specific design that is more informative for a
parameter of interest. For example, if we focus on SC division (η1), the estimated parameter utilities suggest that more
observations should be allocated to earlier days. Looking at the top four design rows for η1 in Figure 6, the marginal
mean utility value does not change even though we are adding more mice and more observation days. This shows
that for η1, the main contribution to information gain is coming from days 0 to 3. Similarly, if we focus on the HSC
self-renewal probability feedback parameter, γ1, we observe that adding data points at later times will lead to higher
utilities. For the same parameter, we observe a lower marginal mean utility for designs where day 6 is not included. We
also note that only a small amount of data is needed to identify the initial conditions, µ1 and µ2. For the full set of
parameter utilities, please refer to Figure A-5 in the Supplemental Materials.
As an example on how to use the parameter utilities for decision making, we can assume we have been given a finite
budget of 20 mice for our perturbation experiment. Looking at the boxed B, C, and D marginal mean utilities in Figure
6, we can compare how the allocation of 20 mice could affect information gain for η1 and γ1. As mentioned previously,
designs with more data points near the initial condition provide higher utilities for η1 but lower utilities on γ1. Design C
provides a reasonable compromise between these two alternatives. For the full set of plots comparing prior and posterior
distributions, please refer to Figure A-9 in the Supplemental Materials. In general, we have found that given a fixed
number of mice, designs with fewer mice at more time points tend to provide better results. Further, as we obtain more
data, we see to reach a point of saturation. see Fig. A-6 in the Supplemental Materials for more design comparisons.
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Figure 6: Individual utilities for the HSC division rate and feedback gain. Top Row. Two mean utility heat maps
for the HSC division rate η1 and self-renewal feedback gain γ1. The mean utility values are relative to the design with
the lowest mean utility value for in each heat map. Four designs (labelled A-D) are selected with increasing mean utility
values and different the sampling frequencies. Bottom Row. Plots of the prior and posterior distributions for η1 and γ1
for the selected experimental designs, as labelled. The true values are shown in green.
4 Discussion
We have presented a new method to find the optimal experimental design for inferring parameters in complex,
mechanistic mathematical models where the experimental data is temporal but not longitudinal.That is, each data point
in time corresponds to a different experimental subject. Our method incorporates Bayesian utility theory in a hierarchical
latent variables framework where the mechanistic model is used to predict the unobserved temporal dynamics. We
quantified the amount of information gained from a specific experimental design as the difference between the prior and
posterior distributions of model parameters using a utility metric based on the Kullback-Leibler divergence function
[29, 30]. Further, by calculating marginal utilities, our proposed framework also allows us to identify the information
gained for each parameter from a specific design. By searching over the space of possible experimental designs, the
best design is the one that maximizes the expected information gain subject to specific constraints, e.g., the fixing the
total number of experimental subjects.
We applied this framework to infer parameters in mathematical models of hematopoiesis in mice that incorporate feed-
back and feedforward regulation of self-renewal and division rates of hematopoietic stem cells (HSC) and multipotent
progenitor (MPP) cells using experimental data on cell counts collected in mice. To obtain a cell count, each mouse had
to be sacrificed and the bone marrow extracted and analyzed. In the experiments, mice were subjected to low doses of
radiation, which decreased the number of HSCs in the bone marrow. After about seven days, the HSC and MPP cell
counts returned to normal.
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We considered a finite grid of possible designs relevant for the radiation experiments where the control parameters
were the number of mice observed at each time point and the time points at which the cell counts were obtained.
Generally, we found that for designs with a fixed number of subjects, having more observation times with fewer mice
replicates leads to higher information gain measured by the expected utility values. Additionally, we found that the
amount of information gain from a specific design can vary significantly across parameters. For example, division rates
are better informed by designs that include more measurements at early times, right after the radiation was applied,
but the feedback parameters are better identified by designs that have more measurements at later times closer to the
equilibrium.
Our method relies on Monte Carlo averaging, MCMC simulation and Bridge sampling which can require a significant
amount of time to implement for complex models. Faster sampling methods [60, 61, 62, 63], efficient numerical solvers
for differential equations [64, 65], and a more efficient exploration of the design space [66] can provide a significant
reduction on computation time.
From the modeling perspective, our framework can be extended to stochastic formulations of the hematopoietic
system with explicit feedback terms that generalize well-known branching process models [23]. Incorporating such
an approach would enable us to model the cellular stochasticities and the heterogeneity of the system components
directly. However, fitting stochastic models tends to be difficult since the likelihood function is generally not available
and approximate Bayesian methods have to be used. Future research directions could involve developing better
implementations of stochastic process models for this problem. Our method could also be extended to incorporate data
on more differentiated cell types in order to provide insight on the response dynamics for more realistic models of the
hematopoietic system with additional feedback mechanisms. To this end, we can include new perturbations, such as the
depletion of specific differentiated cells, into our approach to experimental design.
Additional experiments based on repeated measurements of covariates and cell counts can provide a better understanding
of marginal and population-level responses of hematopoiesis regulation by allowing the model parameters change
across individuals [67].
Furthermore, our approach can be extended to incorporate richer sources of data such as serially sampled barcoded
single cells, which allows for lineage tracking and fate determination.
The hierarchical framework presented in this paper can significantly improve mathematical modeling of hematopoiesis
by determining the required experiments to validate theoretical predictions and to obtain measures of uncertainty of the
model components. In particular, our approach can be used for testing more complex feedback regulation and control
mechanisms. Finally, our work can motivate new collaborations between biologists, data scientists and mathematicians
to develop a unified framework for hypothesis generation, modeling, and experimental validation [68].
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Supplemental Materials
Experimental methods
Mice C57B/6J female mice (Jackson Laboratories), 6-12 weeks of age were used for irradiation and myeloid depletion
experiments. All protocols in mouse was approved by Institutional Animal Use and Care Committee of University of
California, Irvine.
Irradiation of mice To achieve selective depletion of Hematopoietic Stem Cells (HSC), a 50cGy dose of irradiation
from an x-ray source was applied. Control mice did not receive irradiation.
Flow cytometry analysis of cell populations Bone marrow (BM) cells from femur and tibia of control and dosed
mice were isolated by flushing bones. RBC lysed cells (RBC lysis buffer, ebiosciences) were stained with CD34
antibody for one hour and subsequently incubated with a cocktail of biotinylated lineage markers CD3, Gr1, B220,
Ter119, and c-kit, sca1, CD48 for 30 minutes. Streptavidin (SA) conjugated fluorchrome was utilized to detect
biotynalated antibodies. Following fix/ permeabilization and Dnase digestion, anti-BrdU antibody was used to check
BrdU incorporation. Cells were acquired on FACS Arial II and analyzed with Flowjo v10 software
Antibodies Monoclonal antibodies for flow cytometry were biotin mouse lineage panel (559971, BD biosciences),
PE-CF594 Streptavidin (562318, BD biosciences), anti-mouse CD48 (561242, BD biosciences), anti-mouse CD34
eFluor450 (48-0341-82, ebiosciences), anti-mouse Sca1 PE (108108, Biolegend), anti-mouse c-Kit-APC (17-1171-82,
ebiosciences), FITC BrdU flow kit (552598, BD biosciences)
Figure A-1: Perturbation experiment dataset. HSCs and MPPs cellular counts are shown for three different time points.
Dots and marks are use to denote control and perturbation (50 cGy radiation) experiments respectively. Each point
represents a single mouse data.
Relative bias, relative width and coverage In our simulation study, for each design d we used several synthetic
datasets and their corresponding MCMC simulation to infer back the true parameter values. For each of these
simulations, we calculated the mean relative bias, mean relative width of the credible intervals and the coverage.
First, we use the posterior median as a point estimate for each parameter i in the hierarchical model for the j-th
simulation run,
θˆ
(d)
i,j = median(p(θi,j |y(d)j )) (A-1)
1
Figure A-2: Prior and posterior distributions for the mean HSC control and perturbation initial conditions using the
perturbation experiment dataset.
Figure A-3: Prior and posterior distributions for the feedback gain ODE parameters (A, B) and the technical (C) and
biological (D) variability parameters using the perturbation experiment dataset.
where y(d)j represents the j-th synthetic dataset for the design d. The relative bias is calculated by normalizing the
difference between the posterior median and the true value, ie, for the i-th parameter
RelBias(d)i,j =
θˆ
(d)
i,j − θi,j
θi,j
(A-2)
where θ·,j represents the true parameter values for simulation j. The mean relative bias is calculated for each design
averaging over all the relative bias estimates for all the simulations of design d as
Mean RelBias(d)i =
1
N
N∑
j=1
RelBias(d)i,j (A-3)
We define the coverage of a credible interval with a similar interpretation as a frequentist confidence interval is calculated
as the proportion of the time that the interval contains the true value of interest. In this case we calculate the number of
times the true parameter value θi,j is included in the corresponding 95% credible interval Ci,j for the design d.
Coverage(d)i =
1
N
N∑
j=1
1θi,j∈Ci,j (A-4)
2
Prior Posterior
Parameter 2.5% 50% 97.5% 2.5% 50% 97.5%
p0 0.50 0.52 0.60 0.54 0.57 0.64
η1 3.06 5 8.16 3.79 5.85 9.07
η2 2.14 3.86 6.94 1.84 3.01 5.07
γ1 1.50 4 10.7 1.06 2.29 4.88
γ2 1.50 4 10.7 1.89 5.09 12.9
σt 0.39 0.5 0.64 0.41 0.52 0.65
σb 0.39 0.5 0.64 0.42 0.54 0.68
µ1 672 1097 1791 634 915 1317
µ2 5473 8103 11988 6280 8653 11810
Table A-1: Prior vs posterior distributions for the model parameters using the perturbation experiment dataset. The
2.5%, 50% and 97.5% percentiles are provided.
Prior Posterior True
Parameter 2.5% 50% 97.5% 2.5% 50% 97.5%
p0 0.50 0.52 0.60 0.53 0.55 0.54 0.53
η1 1.00 3.84 15.11 5.00 6.51 9.85 9.02
η2 1.00 4.50 20.2 3.98 5.72 10.1 8.37
γ1 1.00 3.15 10 1.77 2.81 3.84 1.97
γ2 1.00 3.15 10 2.44 3.64 5.51 4.03
σt 0.01 0.04 0.18 0.01 0.03 0.05 0.04
σb 0.01 0.04 0.18 0.03 0.03 0.04 0.04
µ1 549 700 890 652 672 693 653
µ2 1462 1996 2743 1839 1904 1970 1970
Table A-2: Prior vs posterior distributions for the model parameters using a synthetic dataset with 7 replicates for 7
consecutive days. The 2.5%, 50% and 97.5% percentiles are provided and the true parameter values are shown on the
rightmost column.
The relative width of the posterior distribution of a parameter is given by the magnitude of the 95% credible interval, ie,
the distance between the 97.5th and 2.5th percentiles as:
RelWidth(d)i,j = q0.975(p(θi,j |y(d)j ))− q0.025(p(θi,j |y(d)j )) (A-5)
and the mean relative width is given by
Mean RelWidth(d)i =
1
N
N∑
j=1
RelWidth(d)i,j (A-6)
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p0
Mean RelBias 0.0 -0.0 -0.0 0.0 0.01 0.0 0.0 -0.0 -0.0 -0.01 0.0 0.0 -0.0 -0.0
Coverage 0.91 0.97 1.0 0.96 0.97 0.93 0.93 1.0 0.93 0.89 0.92 0.91 0.92 0.93
Mean RelWidth 0.05 0.04 0.05 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.03
η1
Mean RelBias -0.12 -0.02 0.09 -0.08 -0.07 -0.01 0.05 0.03 0.08 0.02 0.04 0.06 0.06 0.04
Coverage 0.97 1.0 1.0 1.0 1.0 0.9 0.88 1.0 0.79 0.84 0.96 0.79 0.87 0.84
Mean RelWidth 11.07 5.63 6.69 7.11 5.49 5.27 4.45 4.04 3.31 3.69 3.82 3.61 3.37 3.26
η2
Mean RelBias -0.06 0.03 0.1 -0.06 -0.05 -0.05 0.02 0.04 0.07 -0.01 0.02 0.04 0.04 0.02
Coverage 0.94 1.0 1.0 0.96 1.0 0.9 0.93 0.97 0.83 0.84 0.96 0.88 0.9 0.89
Mean RelWidth 9.97 4.56 7.65 9.63 7.02 8.9 6.33 3.56 3.04 2.92 5.95 5.9 4.99 5.36
γ1
Mean RelBias -0.29 -0.3 -0.59 -0.28 -0.11 -0.15 -0.1 -0.24 -0.23 -0.4 -0.19 -0.07 -0.16 -0.16
Coverage 0.91 0.97 0.89 0.96 0.97 0.9 0.9 0.97 0.81 0.91 0.92 0.86 0.88 0.85
Mean RelWidth 6.98 6.33 6.07 5.81 5.47 4.95 4.94 4.67 4.58 5.69 4.77 4.41 4.18 4.18
γ2
Mean RelBias -0.2 -0.41 -0.02 -0.24 -0.2 -0.22 -0.37 -0.31 -0.3 -0.41 -0.25 -0.29 -0.27 -0.3
Coverage 0.94 0.94 1.0 0.96 0.97 0.9 0.95 0.95 0.95 0.96 0.98 0.95 0.96 0.95
Mean RelWidth 9.01 8.29 9.48 7.94 7.7 6.97 7.38 7.41 7.19 8.41 6.88 6.63 6.5 6.39
σb
Mean RelBias -0.78 -0.68 -0.22 -0.61 -1.06 -0.73 -0.57 -0.71 -0.51 -0.35 -0.37 -0.64 -0.65 -0.52
Coverage 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Mean RelWidth 0.12 0.11 0.08 0.1 0.1 0.1 0.1 0.09 0.08 0.08 0.08 0.09 0.08 0.08
σt
Mean RelBias -0.03 0.01 0.19 0.07 0.25 0.24 0.26 0.21 0.2 0.22 0.24 0.29 0.28 0.28
Coverage 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 0.93 0.92 0.88 0.85 0.85
Mean RelWidth 0.08 0.07 0.05 0.06 0.06 0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.03 0.03
µ1
Mean RelBias -0.02 -0.02 -0.02 -0.03 -0.02 -0.03 -0.03 -0.02 -0.02 -0.01 -0.03 -0.02 -0.03 -0.02
Coverage 0.97 0.97 1.0 0.98 0.97 0.98 0.98 1.0 0.98 0.98 0.98 0.98 0.98 1.0
Mean RelWidth 137.09 110.91 93.11 120.49 108.56 117.0 109.34 92.34 88.81 92.87 93.94 106.56 99.12 98.0
µ2
Mean RelBias 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.02 0.02 0.02 0.02
Coverage 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Mean RelWidth 394.42 371.94 273.44 355.58 347.17 375.67 373.83 340.18 336.57 326.04 319.8 374.47 353.83 357.8
Table A-3: Mean relative bias, coverage and mean relative width of the 95% credible interval for each parameter (rows)
and for all the designs (columns) when the number of replicates per observation time where fixed to 3 mice. For each
entry in the table, 60 different synthetic datasets were used.
Figure A-4: Comparing information gain and goodness of fit for multiple designs We show the ODE solutions
posterior distributions for HSC and MPPs for multiple designs. We selected designs with increasing value of the mean
utility from Fig. 5. The median ODE solution (dashed), the 95% Bayesian credible intervals (bands) and the mean
utility values are shown.
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p0
Mean RelBias 0.01 0.01 -0.01 0.0 0.01 -0.0 0.0 0.0 0.0 -0.0 0.0 0.0 0.0 -0.0
Coverage 0.97 0.97 1.0 0.98 1.0 0.96 0.97 1.0 1.0 1.0 0.94 0.96 0.97 0.97
Mean RelWidth 0.04 0.04 0.04 0.04 0.03 0.03 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.02
η1
Mean RelBias 0.07 0.02 0.05 0.06 0.03 0.1 0.07 0.04 0.06 0.04 0.07 0.07 0.06 0.1
Coverage 0.97 0.97 1.0 0.94 0.97 0.93 0.97 0.97 0.94 1.0 0.97 0.96 1.0 0.94
Mean RelWidth 10.31 5.05 4.63 5.41 3.92 4.36 2.94 2.99 2.19 2.6 2.62 3.07 3.26 3.36
η2
Mean RelBias 0.08 0.02 -0.02 0.02 -0.02 0.06 0.03 0.02 0.03 0.01 0.02 0.04 0.02 0.05
Coverage 0.95 0.97 1.0 0.92 0.97 0.95 0.97 1.0 1.0 1.0 0.97 0.96 1.0 0.94
Mean RelWidth 7.34 4.35 5.09 8.0 5.19 6.79 4.12 3.08 2.48 3.08 3.67 4.39 4.7 4.38
γ1
Mean RelBias -0.07 0.03 -0.46 -0.05 0.05 -0.05 -0.0 -0.0 0.02 -0.36 0.04 0.01 -0.01 -0.08
Coverage 0.92 0.95 0.89 0.96 0.91 0.96 0.92 0.97 0.98 0.9 1.0 0.98 0.97 1.0
Mean RelWidth 5.88 4.65 6.14 4.87 4.35 4.29 3.48 3.47 3.18 4.83 3.0 3.22 3.27 3.38
γ2
Mean RelBias -0.3 -0.27 -0.36 -0.41 -0.45 -0.37 -0.26 -0.24 -0.27 -0.23 -0.48 -0.31 -0.33 -0.47
Coverage 0.92 0.97 0.93 0.96 0.88 0.93 0.97 0.94 0.94 0.96 0.88 0.92 0.95 0.89
Mean RelWidth 9.64 8.33 7.95 7.86 7.62 6.8 5.69 6.22 5.82 6.84 6.2 5.99 6.37 6.1
σb
Mean RelBias -0.74 -0.51 -0.39 -0.63 -0.99 -0.47 -0.7 -0.64 -0.59 -0.41 -0.41 -0.53 -0.54 -0.31
Coverage 1.0 1.0 1.0 1.0 0.97 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Mean RelWidth 0.1 0.09 0.08 0.08 0.08 0.07 0.06 0.08 0.07 0.06 0.07 0.06 0.07 0.06
σt
Mean RelBias -0.02 -0.06 0.12 0.02 0.2 0.07 0.19 0.13 0.13 0.13 0.15 0.18 0.17 0.07
Coverage 1.0 1.0 1.0 1.0 0.97 1.0 1.0 1.0 1.0 1.0 1.0 0.98 0.95 1.0
Mean RelWidth 0.06 0.05 0.04 0.04 0.04 0.03 0.03 0.04 0.03 0.03 0.03 0.02 0.02 0.02
µ1
Mean RelBias -0.04 -0.04 -0.04 -0.04 -0.04 -0.04 -0.03 -0.05 -0.04 -0.05 -0.03 -0.03 -0.04 -0.03
Coverage 0.95 0.9 0.85 0.96 0.91 0.95 0.97 0.79 0.73 0.62 0.91 0.92 0.9 0.94
Mean RelWidth 96.41 83.51 85.52 89.44 82.03 83.48 66.3 73.97 63.96 72.4 73.12 70.75 73.08 72.03
µ2
Mean RelBias 0.05 0.05 0.05 0.05 0.05 0.05 0.04 0.05 0.05 0.05 0.05 0.05 0.05 0.05
Coverage 0.92 0.95 0.96 0.92 0.88 0.93 0.95 0.97 0.94 0.92 0.91 0.88 0.87 0.86
Mean RelWidth 255.16 250.85 233.93 255.83 253.79 249.89 209.19 244.21 227.82 230.94 238.74 231.04 230.26 226.08
Table A-4: Mean relative bias, coverage and mean relative width of the 95% credible interval for each parameter (rows)
and for all the designs (columns) when the number of replicates per observation time is restricted to 7 mice. For each
entry in the table, 60 different synthetic datasets were used.
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Figure A-5: Mean utility values for all the model parameters. The heat maps show the mean utility value for the
labeled parameter normalized by the lowest mean utility. Each parameter utility heat map is scaled differently.
6
Figure A-6: Comparing designs with a fixed number of mice. The mean utility values of the different designs are
compared when the same number of mice is used. The utility value is scaled as in the overall utility from Fig. 5
7
Figure A-7: Coefficient of variation and mean utility values The mean coefficient of variation (CV) for all designs
are obtained and plotted against the parameter utility value. The utility values are raw values and are not normalized
like the utilities in the heat maps.
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Figure A-8: Prior vs posterior mean percent overlap for individual parameters We calculated the mean percent
overlap between the prior and posterior distributions as a complementary measure to the mean utility value for
information gain.
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Figure A-9: Prior vs posterior distributions for sampled designs We show the remaining prior and posterior
distributions for the different parameters (rows) and designs (columns) that were not shown in Fig. 6 in the main text.
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